Novadiscovery

法國 · 資訊科技與服務

Nova In Silico is a French healthtech company focused on enhancing clinical trials through in silico simulation technology. The company has created jinkō, a collaborative clinical trial simulation platform that integrates data science, biology, and medicine to predict clinical outcomes before human trials commence. This innovative approach aims to improve drug development productivity and patient outcomes by using computer simulations to optimize trial design and predict drug efficacy. The jinkō platform allows users to design and simulate clinical trials with a comprehensive model library and virtual patient populations. It facilitates collaborative knowledge management and provides an intuitive interface for clinical trial experts to analyze trial designs. Nova In Silico's technology is utilized by pharmaceutical companies and research organizations to support health technology assessments, accelerate regulatory submissions, and reduce risks associated with human trials. The company actively collaborates with industry partners to promote the adoption of in silico clinical trials and highlight the advantages of computer modeling in drug development.